通过机器学习模型,应用暴露-反应分析来提高Mycophenolate Mofetil在患有免疫媒介病的儿科患者的剂量精度
Lu-Yao Han1, Xiang Chen1, Tian-Shuo Liu2
1School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China.
概括
这项研究开发了药理动力学模型,以优化小儿病中mycophenolate mofetil的剂量. 模型确定了有效暴露于酸的关键因素,从而制定了量身定制的剂量策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科病学 儿科病学
- 免疫抑制是一种免疫抑制.
背景情况:
- 菌酸 (MMF) 对于狼性炎至关重要,并且越来越多地用于儿童免疫媒介脏疾病的非标签.
- 在儿童中优化MMF剂量需要了解基酸 (MPA) 药理动力学.
研究的目的:
- 在中国儿科患者中开发和验证MPA的药理动力学模型.
- 优化MMF的剂量策略,使用免疫介导脏疾病的暴露-反应分析.
主要方法:
- 开发并验证了人口药理动力学 (PopPK) 和机器学习 (ML) 模型,使用来自171名儿科患者的513个MPA度.
- 使用随机森林模型与夏普利添加式扩展 (SHAP) 进行特征重要性.
- 在20名耐药性瘤综合征患者中进行了暴露-反应分析.
主要成果:
- 随机森林模型显示了最佳性能,与白蛋白,和肝/标记预测MPA暴露.
- 确定了减少蛋白尿和疾病进展的治疗值 (AUC0-12h > 30 mg·h/L).
- 为个性化MMF治疗制定了体重和白蛋白调整的剂量方案.
结论:
- 根据暴露-反应分析和模型模拟,提出了分层剂量建议.
- 旨在优化MMF治疗的儿童患者免疫介导脏疾病.
相关概念视频
Renal Failure: Dose Adjustments
167
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
167
Analysis of Population Pharmacokinetic Data
397
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
397


